Elevance Beats Estimates, Raises Forecast on Low Medical Costs
by Bloomberg
Bloomberg— Elevance Health Inc. reported first-quarter adjusted earnings that beat Wall Street estimates and raised its outlook for the year as medical...
Bloomberg—Elevance Health (ELV) Beats Estimates, Raises Forecast on Low Medical Costs. Elevance Health Inc. raised its outlook for the year on first-quarter results that offered some relief to investors after a cyberattack against a rival roiled the health-insurance sector.
CNBC—Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales. The results come as Pfizer tries to regain its footing after the rapid decline of its Covid business.
Yahoo Finance—Elevance Health (ELV) Beats Q1 Earnings Estimates. Elevance Health (ELV) delivered earnings and revenue surprises of 0.95% and 0.36%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?